Vireo Growth VREOF
OTC VREOF
$10.97 -0.01 (-0.09%)
At close: Aug 19, 2026 · 3:35 PM UTC

Vireo Growth (VREOF) Other Non-Current Liabilities (2021 - 2026)

Vireo Growth (VREOF) posted Other Non-Current Liabilities of $30.0 million for Q1 2026, up 1400.0% sequentially from $2.0 million in Q4 2025, and up 80376.42% YoY from N/an in Q1 2025.

Vireo Growth (VREOF) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

Vireo Growth has reported Other Non-Current Liabilities for 6 years, with the latest figure at $30.0 million in Q1 2026.

  • Quarterly Other Non-Current Liabilities rose 80376.42% year-over-year to $30.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.0 million (up 80376.42% YoY) and the FY2025 annual result came in at $2.0 million, changed N/A from the prior year.
  • Other Non-Current Liabilities climbed to $30.0 million in Q1 2026 per VREOF's latest filing, from $2.0 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $30.0 million in Q1 2026 and troughed at $1613.0 in Q4 2022.
  • A 5-year average of $4.1 million and a median of $216938.0 in 2024 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2024 and 2026: Other Non-Current Liabilities retreated 8.66% in 2024, then jumped 80376.42% in 2026.
  • Over 5 years, Other Non-Current Liabilities stood at $1613.0 in 2022, then jumped by 7454.0% to $121846.0 in 2023, then soared by 78.04% to $216938.0 in 2024, then surged by 821.92% to $2.0 million in 2025, then surged by 1400.0% to $30.0 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $30.0 million, $2.0 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.98 Bn 43.02 Bn -
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn
3 Zoetis 31.79 Bn 30.11 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.69 Bn 22.89 Bn 5.10 Bn
5 United Therapeutics 22.25 Bn 19.58 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.58 Bn 15.19 Bn 935.80 Mn
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Vireo Growth 487.39 Mn 345.09 Mn 95.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 30.00 Mn
Dec 31, 2025 2.00 Mn
Sep 30, 2025 1.10 Mn
Jun 30, 2025 10.63 Mn
Mar 31, 2025 37,278.00
Sep 30, 2024 216,938.00
Jun 30, 2024 196,598.00
Dec 31, 2023 121,846.00
Sep 30, 2023 235,577.00
Jun 30, 2023 215,237.00
Dec 31, 2022 1,613.00
Sep 30, 2021 3.08 Mn
Jun 30, 2021 3.71 Mn
Mar 31, 2021 5.24 Mn